Detalles de la búsqueda
1.
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Eur J Haematol
; 109(3): 257-270, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35634931
2.
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.
Infect Dis (Lond)
; 49(11-12): 799-808, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28683646
Resultados
1 -
2
de 2
1
Próxima >
>>